The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: GSK rises, Unilever falls on consumer health bid

Mon, 17th Jan 2022 12:08

(Alliance News) - Stocks in London were on strong footing at the start of the week, with the FTSE 100 climbing despite investor concerns over Unilever's bid for GlaxoSmithKline's consumer healthcare business.

The large-cap index was up 48.48 points, or 0.6%, at 7,591.43 midday Monday. The mid-cap FTSE 250 index was up 132.89 points, or 0.6%, at 22,876.24. The AIM All-Share index was up 5.07 points, or 0.4%, at 1,164.94.

The Cboe UK 100 index was up 0.7% at 753.56. The Cboe 250 was up 0.8% at 20,502.97 and the Cboe Small Companies up 0.3% at 15,773.24.

"The FTSE 100 is in an upbeat mood amid M&A speculation, extending gains after Friday's positive close with the index poised to break above the next major resistance hurdle at 7,600 as it inches towards the January 2020 pre-Covid peak," said Victoria Scholar, head of investment at interactive investor.

GlaxoSmithKline shares rose 3.7% after Unilever confirmed making an approach for GSK Consumer Healthcare, believing that the business would a be a "strong strategic fit" with its own consumer goods.

On Saturday, Glaxo confirmed that it had received three bids for its Consumer health arm from Unilever, the latest being for GBP50 billion in cash and shares. The business was formed in August 2019 as a joint venture with Pfizer, which holds a 32% interest, while GSK holds the remaining 68%.

All three proposals were rejected by the Brentford-based pharmaceutical group, on the grounds that they all undervalued the business and its future prospects.

Unilever said its interest in GSK Consumer Health follows an extensive process reviewing how it can reposition its portfolio into higher growth categories.

Reckitt Benckiser, maker of Nurofen painkillers, was up 2.8% in a positive M&A read-across.

However, Unilever shares tanked 7.5% on a day of broad-based gains in the FTSE 100.

"The negative share price reaction probably reflects investors' fears that Unilever is going to come back with a higher offer and potentially pay too much," said Russ Mould, investment director at AJ Bell.

With US financial markets shut on Monday for Martin Luther King Jr day, Pfizer shares were unable to react to the news.

In mainland Europe, the CAC 40 in Paris was up 0.6%, while the DAX 40 in Frankfurt was up 0.4% on Monday.

Back in London, shares in Taylor Wimpey rose 3.3% after the UK housebuilder said 2021 results will be in line with its prior guidance, following strong demand for houses and improved operating margins.

Total UK home completions were up 47% to 14,087 from 9,609 in 2020, with 18% of completions being affordable homes. Selling prices for UK houses were up overall by 4.2% to GBP300,000 from GBP288,000 in 2020. This includes a 3% year-on-year increase for private completions, which sold on average for GBP332,000.

Antofagasta was up 2.7% after UBS upgraded the Chilean miner to Neutral from Sell. The industrial mining sector on Monday also was lifted by the latest Chinese economic growth figures, with Glencore up 1.7% in midday trade in London and Anglo American up 1.0%.

The world's second-biggest economy, a key buyer of minerals, expanded 8.1% in 2021, National Bureau of Statistics data showed, beating forecasts of 8.0% in an AFP poll, and the 2.3% reading for 2020. But much of that growth came in the first half of the year, with the Chinese economy shaken by a series of shocks towards the end of 2021.

The gross domestic product figures came as China's central bank cut the rate on its one-year policy loans to 2.85%, the first drop since April 2020 at the height of the pandemic and a clear signal from authorities that the outlook this year remains uncertain.

Topping London's mid-cap FTSE 250 index was Cineworld, up 8.3% at midday and continuing to rally after Friday's news that the cinema operator was cash flow positive in its fourth quarter.

Capital & Counties rose 2.9%. The property firm said its London-based flagship asset, Covent Garden, had a strong second half despite the fast-spreading Omicron variant of coronavirus.

As at December 31, the independent property valuation of Covent Garden stood at GBP1.7 billion, representing a like-for-like increase of 4.6% in the second half of 2021. However, the asset depreciated 0.6% for the full year ended December 31.

Elsewhere in London, WAG Payment Solutions rose 13% after the toll and fuel payments processor said trading was strong in fourth quarter. WAG expects to deliver full-year revenue growth of 18%, to stand at at least EUR152 million.

In the currency space, sterling was quoted at USD1.3662 at midday, soft against USD1.3675 at the London equities close on Friday.

UK Prime Minister Boris Johnson has reportedly been interviewed as part of the investigation into 'partygate' allegations, as claims of another lockdown breach in No 10 surfaced.

Johnson is said to have "shared what he knows" with senior civil servant Sue Gray about alleged parties in Downing Street as she prepares to publish her report into claims of coronavirus rule flouting as soon as this week, the Daily Telegraph reported.

In a bid to survive the storm, reports have suggested Johnson could overhaul his top team, with the likes of his principal private secretary, Martin Reynolds, who sent an email inviting staff to enjoy the good weather in the No 10 garden in May 2020, being shown the door as part of a move said to have been dubbed 'Operation: Save Big Dog'.

The euro traded at USD1.1410 on Monday, down versus USD1.1423. Against the yen, the dollar was quoted at JPY114.51, up from JPY113.82 late Friday.

Gold was quoted at USD1,820.43 an ounce on Monday, up from USD1,818.19 on Friday. Brent oil was trading at USD85.85 a barrel, higher than USD85.56.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.